EUVIMEDEUVIMED entdecken
Open Access

Natural killer cell-specific chimeric antigen receptor enhances CAR NK cell functions and anti-tumor activity

Changqing Pan, You Zhai, Zhongliang Cui, Yiyun Yin, Menghui Xu, Di Wang, Yishuo Sun, Jiazheng Zhang, Chen Wang, Ziwei Li, Mingchen Yu, Zhongfang Shi und 3 weitere

Theranostics · 06.11.2025 · 15 (17) · 9344-9358

DOI: 10.7150/thno.120909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 06.11.2025. Verfasst von Changqing Pan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, PR China. Hauptthemen laut MEDLINE: Killer Cells, Natural, Receptors, Chimeric Antigen, Immunotherapy, Adoptive, Melanoma, Experimental. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Unlike T cells, natural killer (NK) cells lack a dominant activating receptor analogous to the T cell receptor (TCR) that governs their activation. Whether chimeric antigen receptor (CAR) constructs engineered specifically for T cells can effectively drive NK cell activation remains unresolved. NK cells inherently possess non-specific recognition capacities and exert broad-spectrum cytotoxicity against diverse tumor targets. However, the complexity of receptor-ligand interactions between CAR NK cells and susceptible target cells has impeded efforts to delineate the specific functional contributions of individual CAR constructs.

Methods

CAR NK cells were generated via electroporation. The murine B16 melanoma cell line was modified to express various target proteins using lentiviral transduction. In vitro functional assays, including conjugate formation, granule polarization, degranulation, cytotoxicity, and cytokine production, were employed to assess CAR NK cell efficacy. Recombinant protein-coated beads were used to investigate downstream activation signaling pathways. The in vivo antitumor activity of CAR NK cells was evaluated using NPG mouse xenograft models.

Results

B16 cell line was first validated to be a suitable model for specifically assessing CAR construct function in CAR NK cells. Among nine distinct CAR molecules generated, the construct incorporating the NKG2DTM-2B4-FCER1G exhibited the most potent capacity to enhance NK cell-mediated functionalities. Consistent with these functional improvements, this CAR construct induced robust phosphorylation of key activation pathways, including AKT, VAV1, ERK, PLCγ1, and NF-κB.

Conclusions

The CAR construct incorporating the NKG2DTM-2B4-FCER1G is demonstrated to be the most effective in enhancing NK cell functionality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalReceptors, Chimeric AntigenImmunotherapy, AdoptiveMelanoma, ExperimentalAnimalsMiceCell Line, TumorHumansMice, Inbred C57BLXenograft Model Antitumor AssaysCytotoxicity, ImmunologicLymphocyte ActivationSignal TransductionNK Cell Lectin-Like Receptor Subfamily K

Stichwörter der Autor:innen

CAR NKNK-92MIglioblastomaiPSClymphoma

Substanzen

Receptors, Chimeric AntigenNK Cell Lectin-Like Receptor Subfamily K

Autor:innen und Institutionen

  • Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, PR China.
  • Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, PR China.
  • Department of Pathophysiology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, PR China.
  • Chinese Glioma Genome Atlas Network (CGGA) and Asian Glioma Genome Atlas Network (AGGA), Beijing, PR China.
  • Brain Tumor Center, Beijing Institute of Brain Disorders, Capital Medical University, Beijing 100070, PR China.
  • Beijing Engineering Research Center of Targeted Drugs and Cell Therapy for CNS Tumors, Beijing 102600, PR China.

Zitieren

APA

Pan, C., Zhai, Y., Cui, Z., Yin, Y., Xu, M., Wang, D., Sun, Y., Zhang, J., Wang, C., Li, Z., Yu, M., Shi, Z., Li, G., Jiang, T., & Zhang, W. (2025). Natural killer cell-specific chimeric antigen receptor enhances CAR NK cell functions and anti-tumor activity. Theranostics, 15(17), 9344-9358. https://doi.org/10.7150/thno.120909

Vancouver

Pan C, Zhai Y, Cui Z, Yin Y, Xu M, Wang D, et al. Natural killer cell-specific chimeric antigen receptor enhances CAR NK cell functions and anti-tumor activity. Theranostics. 2025;15(17):9344-9358. doi:10.7150/thno.120909

BibTeX
@article{Pan2025,
  author = {Pan, Changqing and Zhai, You and Cui, Zhongliang and Yin, Yiyun and Xu, Menghui and Wang, Di and Sun, Yishuo and Zhang, Jiazheng and Wang, Chen and Li, Ziwei and Yu, Mingchen and Shi, Zhongfang and Li, Guanzhang and Jiang, Tao and Zhang, Wei},
  title = {Natural killer cell-specific chimeric antigen receptor enhances CAR NK cell functions and anti-tumor activity},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {17},
  pages = {9344--9358},
  doi = {10.7150/thno.120909}
}
Kostenlos starten →